¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Annals of Hepatology

Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us

X Facebook

Contact

Email

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2025

6.2

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2025

9.6

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2025

1.446

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2025

1.378

Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more

Time to first decision

8 days

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Cover Vol. 29. Issue S1.

Vol. 29. Issue S1.

Abstracts of the 2023 Annual Meeting of the ALEH

(February 2024)

EDITORIAL BOARD

Ann Hepatol. 2024;29 Supl 1: 101290

Full text access

Share

Abstracts of the 2023 Annual Meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Ann Hepatol. 2024;29 Supl 1: 101187

Full text access

Share

P-1 EFFECTIVENESS AND SAFETY OF BARIATRIC SURGERY IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS SECONDARY TO METABOLIC ASSOCIATED FATTY LIVER DISEASE IN A TERTIARY REFERENCE HOSPITAL

Ana Luiza Gomes Reis, Marcella Motta Lucindo Duarte, Renato Gama Altike, Patrícia Momoyo Youshimura, Danilo Razente, Miller Barreto de Brito e Silva, Marco Aurélio Santo, Mário Guimarães Pessôa, Claudia Pinto Oliveira

Ann Hepatol. 2024;29 Supl 1: 101188

Full text access

Share

P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.

Samael Rodríguez, Rebeca Rosas, Angel Omar Vazquez, Ivonne Palacios, Ricardo De la Rosa, Rebeca Escutia, Josep Jiménez, Luis Felipe Jave, ... Juan Armendariz

Ann Hepatol. 2024;29 Supl 1: 101189

Full text access

Share

P-3 PIRFENIDONE PREVENTS OBESITY-ASSOCIATED NONALCOHOLIC STEATOHEPATITIS AND CARDIAC FIBROSIS THROUGH HORMONAL REPROGRAMMING

Jorge Gutiérrez, Daniel López, Ana Soledad Sandoval, Ángel Omar Vázquez, Jonathan Samael Rodríguez, Juan Armendáriz

Ann Hepatol. 2024;29 Supl 1: 101190

Full text access

Share

P-4 HETEROGENEITY OF PRE-LIVER TRANSPLANT EVALUATION PRACTICES IN LATIN AMERICA COUNTRIES: THE LIVER TRANSPLANT ALEH SPECIAL INTEREST GROUP, INTERNATIONAL SURVEY 2023

Victoria Mainardi, Josemaría Menéndez, Solange Gerona, Alejandra Villamil, Josefina Pages, Manuel Mendizabal, Sergio López, Adriana Varon, ... Rodrigo Zapata

Ann Hepatol. 2024;29 Supl 1: 101191

Full text access

Share

P-5 APACHE STUDY DESIGN TO EVALUATE THE EFFICACY AND SAFETY OF PLASMA EXCHANGE WITH HUMAN SERUM ALBUMIN 5% ON SHORT-TERM SURVIVAL IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE AT HIGH RISK OF HOSPITAL MORTALITY.

Nikolaos Pyrsopoulos, Giovanni Perricone, Jasmohan S. Bajaj, Thierry Gustot, Thomas Reiberger, Mireia Torres, Peter Nelson, Javier Fernandez

Ann Hepatol. 2024;29 Supl 1: 101192

Full text access

Share

P-6 PREVALENCE AND CLINICAL CHARACTERISTICS OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE IN MÉXICO

Erick Augusto Jasso, Jesús Alejandro Ruiz, Antonio Olivas, Luis Carlos Chávez, Juan Adrian Torres, Alfonso Fernández, Abraham Ramos, Josealberto Sebastiano Arenas, ... Aldo Torre

Ann Hepatol. 2024;29 Supl 1: 101193

Full text access

Share

P- 7 RISK FACTORS FOR NON-ALCOHOLIC FATTY LIVER DISEASE AFTER LIVER TRANSPLANTATION

Marcelo Arouca, Rafael Mendes, Guilherme Grossi, Mateus Jorge, Henrique Drumond, Livia Manussakis, Luis Henrique De Oliveira, Leticia Chaves, ... Luciana Costa

Ann Hepatol. 2024;29 Supl 1: 101194

Full text access

Share

P-8 OSTEOSARCOPENIA AND FIBROSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE

Débora Soares, Priscila Flores, Maria Auxiliadora Saad, Jenaine Rosa Emiliano, Raphael Moura, Rogério de Oliveira, Amanda Maria Felix, Jordanna Mendes, ... Carlos Roberto de Andrade

Ann Hepatol. 2024;29 Supl 1: 101195

Full text access

Share

P-9 AUTOIMMUNE LIVER DISEASES IN LATIN AMERICA: A WEB-BASED SURVEY

Claudia Alves, Guilherme Grossi Lopes, Debora Raquel B, Eduardo Luiz Rachid, Daniela Chiodi, Javier Brahm, Carlos Bernardo Sánchez, Manuel Gatica, ... Mario Guimaraes

Ann Hepatol. 2024;29 Supl 1: 101196

Full text access

Share

P-10 THE EFFECTS OF CHILEAN RESPONSE TO COVID-19 ON ALCOHOL CONSUMERS: A NATURAL POLICY EXPERIMENT

María Jesús Fuenzalida, Óscar Corsi, Valentina Cox, Luis Antonio Díaz, Juan Pablo Arab, Paula Margozzini, José Marín

Ann Hepatol. 2024;29 Supl 1: 101197

Full text access

Share

P-11 PRIMARY BILIARY CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS HEPATIC OVERLAP SYNDROME – CASE REVIEW

Federico Aronsohn, Jaime Poniachik, Álvaro Urzúa

Ann Hepatol. 2024;29 Supl 1: 101198

Full text access

Share

P-12 MELD 3.0 IS THE BEST PREDICTOR OF MORTALITY IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF)

Ernesto Javier Medina-Avalos, Fátima Higuera-de la Tijera, Miguel Yael Carmona-Castillo, Sandra Teutli- Carrión, Claudia Leticia Dorantes-Nava, José Luis Pérez-Hernández, Daniel Santana-Vargas

Ann Hepatol. 2024;29 Supl 1: 101199

Full text access

Share

P-13 IMPACT OF SPONTANEOUS BACTERIAL PERITONITIS ON THE OUTCOME OF PATIENTS WITH HEPATIC CIRRHOSIS

Sandra Teutli, Claudia Leticia Dorantes, Miguel Yael Carmona, Ernesto Javier Medina, Daniel Santana, Maria De Fátima Higuera, Jose Luis Perez

Ann Hepatol. 2024;29 Supl 1: 101200

Full text access

Share

P-14 SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS: PREVALENCE AND ANTIBIOTIC RESISTANCE PATTERNS

Bruno Campos, Eliabe Silva, Guilherme Grossi Lopes, Guilherme De Oliveira, Joao Pedro Rocha, Júlia Cunha, Laura Normando, Laura Melo, ... Cláudia Alves

Ann Hepatol. 2024;29 Supl 1: 101201

Full text access

Share

P-15 HELICOBACTER PYLORI AS A RISK FACTOR FOR THE DEVELOPMENT OF MANIFEST ENCEPHALOPATHY AND OTHER COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS AT THE EUGENIO ESPEJO HOSPITAL IN THE PERIOD MAY 2019-JUNE 2022

Mariana Gabriela Orozco, Giadira Karolina Espinosa, Wilson Enrique Carrera, Wendy Patricia Calderón, Hugo Pereira

Ann Hepatol. 2024;29 Supl 1: 101202

Full text access

Share

P- 16 HEPATOCELLULAR CARCINOMA IN CENTRAL AMERICA: A MULTIDISCIPLINARY APPROACH IN A COSTA RICAN COHORT

María Castro, Francisco Vargas, María Lynch, Aldo Carvajal, Esteban Cob, Daniel Mondragón, Víctor Alvarado, Alejandra Ochoa, ... Pablo Coste

Ann Hepatol. 2024;29 Supl 1: 101203

Full text access

Share

P- 17 LIVER TESTS ABNORMALITIES AS PROGNOSTIC MARKERS OF DEATH IN PATIENTS HOSPITALISED BY COVID-19. A COHORT STUDY

Andrés Fernando Rodriguez-Gutierrez, Sergio Mauricio Moreno, Camilo Andrés Duarte

Ann Hepatol. 2024;29 Supl 1: 101204

Full text access

Share

P- 18 ANASTROZOLE MAY NOT BE ASSOCIATED FATTY LIVER DISEASE AND HEPATIC FIBROSIS IN WOMEN WITH BREAST CANCER

Mateus Jorge, Guilherme Grossi, Mísia Joyner De Sousa, Adriana Maria Lamego, Carolina Martins, Paulo Henrique Costa, Fernanda Alves, Julia Cunha, ... Claudia Alves

Ann Hepatol. 2024;29 Supl 1: 101205

Full text access

Share

P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY

Francisco Idalsoaga, Luis Antonio Díaz, Oscar Corsi, Gustavo Ayares, Jorge Arnold, Winston Dunn, Yanming Li, Ashwani Singal, ... Juan Pablo Arab

Ann Hepatol. 2024;29 Supl 1: 101206

Full text access

Share

P-20 OXIDATIVE STRESS MARKERS IN ALCOHOLIC LIVER DISEASE

GABRIELA GUTIÉRREZ, Abigail Hernandez, Zaira Medina, Marisela Hernandez, Moisés Martínez, José Luis Pérez, Fátima Higuera, Jacqueline Córdova

Ann Hepatol. 2024;29 Supl 1: 101207

Full text access

Share

P-21 FIBROSIS DEVELOPMENT AND MALIGNANCIES ARE DELAYED BY PIRFENIDONE WHILE INCREASING SIRT1 NUCLEAR TRANSLOCATION AND HISTONE 3 DEACETYLATIONS IN A HEPATOCARCINOMA MODEL

Hugo Christian Monroy, Scarlet Arceo, Araceli Guadalupe Cabral, Marina Galicia, Juan Armendariz

Ann Hepatol. 2024;29 Supl 1: 101208

Full text access

Share

P-22 UNCOVERING INSIGHTS ON ACUTE VARICEAL HEMORRHAGE: A CROSS- COUNTRY SURVEY STUDY ON THE MANAGEMENT OF UPPER GASTROINTESTINAL BLEEDING IN LATIN AMERICA

Jesus Ruiz, Wagner Enrique Ramirez, Antonio Olivas, Luis Carlos Chávez, Erick Jasso, Josealberto S. Arenas, Thamy Leidy Beltré, Jose Carlos Jésus Ticona, ... Luis Eduardo Zamora

Ann Hepatol. 2024;29 Supl 1: 101209

Full text access

Share

P- 23 HEPATOCELLULAR CARCINOMA IN CENTRAL AMERICA: EPIDEMIOLOGY OF A COSTA RICAN COHORT

Francisco Vargas, María Lynch, María Castro, Aldo Carvajal, Esteban Cob, Victor Alvarado, Daniel Mondragón, Alejandra Ochoa, ... Pablo Coste

Ann Hepatol. 2024;29 Supl 1: 101210

Full text access

Share

P- 24 DISTRIBUTION OF HEPATITIS C GENOTYPES IN THE ARGENTINE POPULATION IN THE LAST TEN YEARS

Javier Alejandro Sfalcin, Alan Gomez, Tomás Fernandez, Dolores Gagey, Pablo Gornitz, Andrea Lucca, Maribel Martinez Wassaf, Néstor Portela, ... Fabián Fay

Ann Hepatol. 2024;29 Supl 1: 101211

Full text access

Share

P- 25 METABOLIC, HISTOLOGICAL AND INFLAMMATORY BENEFITS IN A MURINE MODEL OF ALCOHOLIC STEATOHEPATITIS USING METHYL-GROUP DONOR SUPPLEMENTATION

Carolina Diaz, Angel Omar Vázquez, Rebeca Rosas, Samael Rodriguez, Rebeca Escutia, Marina Galicia, Juan Armendariz, Ana Sandoval

Ann Hepatol. 2024;29 Supl 1: 101212

Full text access

Share

P- 26 FIBROSIS FREQUENCY IN A COHORT OF METABOLIC FATTY LIVER DISEASE RISK PATIENTS

Priscila Flores, Débora Soares, Maria Auxiliadora Saad, Guillermo Cocavelarde, Carlos Roberto, Hévila Passos, Raphael Carreiro, Gabriela Machado, ... Ana Ester de Paula

Ann Hepatol. 2024;29 Supl 1: 101213

Full text access

Share

P-27 DESCRIPTIVE STUDY ON PATIENTS WITH HEPATOCARCINOMA IN A PUBLIC HOSPITAL 2018-2023

Paula Andrea Huerta, Matías Alberto Salazar, Joaquín Jensen, Alexandra Ginesta

Ann Hepatol. 2024;29 Supl 1: 101214

Full text access

Share

P-28 HEPATOTOXICITY OF PESTICIDES USED IN VITICULTURES IN THE SOUTHERN BRAZIL REGION

Nelson David Suarez, Sheila de Castro Cardoso, Raquel Boff, Patricia Gabriela Riedel, Camila Baldin, Franciele Fatima Lopes, Eduardo Natan Maraschin, Debora Silva, ... Dvora Joveleviths

Ann Hepatol. 2024;29 Supl 1: 101215

Full text access

Share

P-29 INCIDENCE AND ASSOCIATED FACTORS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION IN A SINGLE CENTER IN PERU: A RETROSPECTIVE STUDY.

Williams Celedonio Campos, César Castro Villalobos, Rosario Mayorga Márquez, Jorge Garavito-Rentería, Rommel Zambrano- Huailla

Ann Hepatol. 2024;29 Supl 1: 101216

Full text access

Share

P- 30 IMPACT OF SELF-REPORTED ANCESTRY IN HEPATOCELLULAR CARCINOMA IN HISPANIC POPULATIONS

Spencer Goble, Cindy Narvaez-Barbecho, Manaswita Tappata, Jhon Prieto, Domingo Balderramo, Enrique Carrera, Javier Diaz Ferrer, Marco Arrese, ... Jose Debes

Ann Hepatol. 2024;29 Supl 1: 101217

Full text access

Share

P-31 METHOTREXATE SEEMS NOT TO BE ASSOCIATED WITH LIVER FIBROSIS IN RHEUMATOID ARTHRITIS PATIENTS

Leandro Augusto De Araújo, Maria Fernanda Brandão De Resende, Mateus Jorge, Guilherme Grossi, Sabrina Da Siva, Kassia Burini, Mateus Saraiva, Thais Galdino, ... Luciana Costa

Ann Hepatol. 2024;29 Supl 1: 101218

Full text access

Share

P- 32 VALIDATION OF LILLE-4 VERSUS LILLE-7 TO PREDICT SHORT-TERM MORTALITY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS

Claudia Leticia Dorantes, María de Fátima Higuera, Alfredo Servín, Gabriela Gutiérrez, Miguel Yael Carmona, Sandra Teutli, Ernesto Javier Medina, José Luis Pérez

Ann Hepatol. 2024;29 Supl 1: 101219

Full text access

Share

P- 33 FREQUENCY, PROPHYLAXIS AND MANAGEMENT OF VARICEAL BLEEDING IN PATIENTS WITH LIVER CIRRHOSIS IN A RETROSPECTIVE MULTICENTER COHORT FROM SOUTH AMERICA

Domingo Balderramo, Jhon Prieto, Javier Eslava, Juan Diego, María Teresita Carreño, Daniela Moreno, Robin German Prieto, Carlos Sanchez, ... Jose Debes

Ann Hepatol. 2024;29 Supl 1: 101220

Full text access

Share

P- 34 TOMOGRAPHIC ASSESMENT OF SARCOPENIA IN CIRRHOTIC PATIENTS BEFORE LIVER TRASPLANT: PREVALENCE, ASSOCIATED FACTORS AND POST-SURGERY OUTCOMES IN A COHORT OF CHILEAN PATIENTS

Kenia Orellana, Francisca Araya, Abraham Gajardo, Giselle Arévalo, Isabel Lagos, Jaime Poniachik, Juan Pablo Roblero

Ann Hepatol. 2024;29 Supl 1: 101221

Full text access

Share

P- 35 COMPLICATIONS ASSOCIATED TO THE LIVER TRANSPLANTATION IN PATIENTS WITH CIRRHOTIC CARDIOMYOPATHY

José Ignacio Ruiz, Verónica Marín, Daniela Simian, Pamela Smith, Juan Pablo Roblero, Álvaro Urzúa, Máximo Cattaneo, Marcelo Llancaqueo, ... Jaime Poniachik

Ann Hepatol. 2024;29 Supl 1: 101222

Full text access

Share

P- 36 ACUTE ON CHRONIC LIVER FAILURE IN LATIN AMERICA: SUB-ANALYSIS OF A SYSTEMATIC REVIEW AND META-ANALYSIS

Gabriel Mezzano, Herman Edgardo Aguirre, Javier Perez-Valenzuela, Aaron Cortes, Adria Juanola, Andrés Cardenas, Elsa Sola, Ruben Hernaez

Ann Hepatol. 2024;29 Supl 1: 101223

Full text access

Share

P- 37 CLINICAL EVOLUTION OF PATIENTS WITH AUTOIMMUNE LIVER DISEASES IN A LIVER TRANSPLANTATION CENTER

Harlim Rodríguez, Marcia Samada, Teresita Pérez, Lisset Barroso, Zucel Danay Cruz, Kenia Yunarkis Valenzuela, Lissette Chao, Yunia Tusen, Mirta Infante

Ann Hepatol. 2024;29 Supl 1: 101224

Full text access

Share

P- 38 HEPATITIS E VIRUS IN PATIENTS WITH CHRONIC LIVER DISEASE IN COLOMBIA

Jhon Edison Prieto, Anabella Clara Fantilli, María Belén Pisano, Maribel Martínez, Octavio Giayetto, Domingo Balderramo, Viviana Elizabeth Re, Robin German Prieto, ... Andre Boonstra

Ann Hepatol. 2024;29 Supl 1: 101225

Full text access

Share

P- 39 N-ACETYL CYSTEINE ATTENUATES ALTERATIONS GENERATED IN EXPERIMENTAL LIVER STEATOSIS INDUCED BY CHRONIC ALCOHOL CONSUMPTION PLUS A HYPERCALORIC DIET

Marina Galicia, Katia Berenice Roa, Angel Omar Vazquez, Hugo Christian Monroy, Rebeca Rosas, Ana Soledad Sandoval, Juan Armendariz

Ann Hepatol. 2024;29 Supl 1: 101226

Full text access

Share

P- 40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY

Francisco Idalsoaga, Luis Antonio Diaz, Oscar Corsi, Gustavo Ayares, Jorge Arnold, Winston Dunn, Yanming Li, Ashwani Singal, ... Juan Pablo Arab

Ann Hepatol. 2024;29 Supl 1: 101227

Full text access

Share

P-41 IMPACT OF CHOLEMIC NEPHROSIS ON RENAL FAILURE IN CIRRHOTIC PATIENTS

Silvia Johanna Lozada, María de Fátima Higuera, Daniel Santana, Leonardo Samuel Juarez, Cristhian Calderon, Carlos Barragan, Ricardo Garcia, Vilma Hernandez, Jose Luis Perez

Ann Hepatol. 2024;29 Supl 1: 101228

Full text access

Share

P- 42 METABOLIC ASSOCIATED FATTY LIVER DISEASE AND BODY COMPOSITION MEASUREMENT

Maria Auxiliadora Nogueira, Priscila Flores, Debora Vieira, Rosa Leonora Salerno, Mariana Sophia Almeida Santos, Julio Alves, Maria Eduarda Costa, Aline De Araújo Sousa, ... Caroline Ramos

Ann Hepatol. 2024;29 Supl 1: 101229

Full text access

Share

P- 43 HCV TESTING AND TREATMENT IN FOUR BRAZILIANS’ CORRECTIONAL SETTINGS

Joao Batista da Silva, Eric Soares, Alexandre Munhoz, Raquel Dalpaz Dias, Ana Paula Moraes da Silva Barrufi, Janieri Rosso Dassoler, Tiane Ramos do Canto, Thaís Alves Martins Candido, ... Patricia Rodrigues Oenning

Ann Hepatol. 2024;29 Supl 1: 101230

Full text access

Share

P-44 OUTCOMES AND MORTALITY OF PATIENTS WITH HEPATOPULMONARY SYNDROME AT A QUATERNARY LIVER TRANSPLANT CENTER

Marcus Vinícius De Acevedo Garcia Gomes, Diogo Delgado Dotta, Juliana Marquezi Pereira, Roque Gabriel Rezende Lima, Evandro de Souza Oliveira, Luiz Augusto Carneiro D'Albuquerque, Carlos Viana Poyares Jardim, Patricia Kittler Vitorio, ... Débora Raquel Benedita Terrabuio

Ann Hepatol. 2024;29 Supl 1: 101231

Full text access

Share

P-45 EVALUATION OF THE ALBI SCORE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH YTTRIUM-90 (90Y)

Stefanny Cornejo, Yailin Fabiola Velazquez, Blanca Zapote, Itzia Verduzco, Erika Santiago, Salvador Amezquita, Juan Salvador Garcia, Miguel Angel Mendoza, Eira Cerda

Ann Hepatol. 2024;29 Supl 1: 101232

Full text access

Share

P- 46 AMOUNT OF DIETETIC FAT AND CARBOHYDRATE TYPES RELATED TO HEPATIC STEATOSIS IN A GROUP OF MEXICAN ADULTS

Sophia Eugenia Martínez, Graciela Elia Castro, Ashuin Kammar, Luis Uscanga

Ann Hepatol. 2024;29 Supl 1: 101233

Full text access

Share

P- 47 ACCURACY OF MAFLD-S SCORE TO DIAGNOSE HEPATIC STEATOSIS IN A GROUP OF APPARENTLY HEALTHY PEOPLE.

Luis Carlos Chávez, Juan Adrián Torres, Sophía Eugenia Martínez, Ashuin Kammar, Antonio Olivas, Jesús Alejandro Ruiz, Luis Federico Uscanga, Graciela Castro

Ann Hepatol. 2024;29 Supl 1: 101234

Full text access

Share

P- 48 EFFECT OF THE COMBINATION OF ORLISTAT AND L-CARNITINE ON THE QUALITY OF LIFE (SF.36) IN 16 OVERWEIGTH PATIENTS

Miguel Yael Carmona, Saúl André Vera, María De Fatima Higuera, Livan Delgado, Santiago Camacho

Ann Hepatol. 2024;29 Supl 1: 101235

Full text access

Share

Publish in

Annals of Hepatology

Affiliated societies

asdasdasd